日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glycogen synthase kinase 3 activity enhances liver inflammation in MASH

糖原合成酶激酶3活性加剧MASH中的肝脏炎症

Khoury, Mireille; Guo, Qianqian; Furuta, Kunimaro; Correia, Cristina; Meroueh, Chady; Kim Lee, Hyun Se; Warasnhe, Khaled; Valenzuela-Pérez, Lucía; Mazar, Andrew P; Kim, Iljung; Noh, Yung-Kyun; Holmes, Heather; Romero, Michael F; Sussman, Caroline R; Pavelko, Kevin D; Islam, Shahidul; Bamidele, Adebowale O; Hirsova, Petra; Li, Hu; Ibrahim, Samar H

Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation

胶质瘤干细胞对三氧化二砷疗法的差异性反应受MNK1和mRNA翻译调控

Bell, Jonathan B; Eckerdt, Frank; Dhruv, Harshil D; Finlay, Darren; Peng, Sen; Kim, Seungchan; Kroczynska, Barbara; Beauchamp, Elspeth M; Alley, Kristen; Clymer, Jessica; Goldman, Stewart; Cheng, Shi-Yuan; James, C David; Nakano, Ichiro; Horbinski, Craig; Mazar, Andrew P; Vuori, Kristiina; Kumthekar, Priya; Raizer, Jeffrey; Berens, Michael E; Platanias, Leonidas C

9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma

9-ING-41 是一种小分子糖原合成酶激酶-3抑制剂,对神经母细胞瘤有效。

Ugolkov, Andrey V; Bondarenko, Gennadiy I; Dubrovskyi, Oleksii; Berbegall, Ana P; Navarro, Samuel; Noguera, Rosa; O'Halloran, Thomas V; Hendrix, Mary J; Giles, Francis J; Mazar, Andrew P

Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer

分子通路:重新审视糖原合成酶激酶-3β作为癌症治疗靶点

Walz, Amy; Ugolkov, Andrey; Chandra, Sunandana; Kozikowski, Alan; Carneiro, Benedito A; O'Halloran, Thomas V; Giles, Francis J; Billadeau, Daniel D; Mazar, Andrew P

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models.

GSK-3 抑制剂 9-ING-41 与 CCNU 联合治疗可治愈患者来源异种移植模型中的原位化疗耐药性胶质母细胞瘤

Ugolkov Andrey, Qiang Wenan, Bondarenko Gennadiy, Procissi Daniel, Gaisina Irina, James C David, Chandler James, Kozikowski Alan, Gunosewoyo Hendra, O'Halloran Thomas, Raizer Jeffrey, Mazar Andrew P

Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells

尿激酶型纤溶酶原激活物受体表达在胰腺癌中的预后影响:恶性细胞与间质细胞

de Geus, Susanna Wl; Baart, Victor M; Boonstra, Martin C; Kuppen, Peter Jk; Prevoo, Hendrica Ajm; Mazar, Andrew P; Bonsing, Bert A; Morreau, Hans; van de Velde, Cornelis Jh; Vahrmeijer, Alexander L; Sier, Cornelis Fm

Melanoma Cells Block PEDF Production in Fibroblasts to Induce the Tumor-Promoting Phenotype of Cancer-Associated Fibroblasts

黑色素瘤细胞通过抑制成纤维细胞中PEDF的产生来诱导癌相关成纤维细胞的促肿瘤表型

Nwani, Nkechiyere G; Deguiz, Maria L; Jimenez, Benilde; Vinokour, Elena; Dubrovskyi, Oleksii; Ugolkov, Andrey; Mazar, Andrew P; Volpert, Olga V

GSK-3 inhibition overcomes chemoresistance in human breast cancer

GSK-3抑制剂可克服人类乳腺癌的化疗耐药性

Ugolkov, Andrey; Gaisina, Irina; Zhang, Jin-San; Billadeau, Daniel D; White, Kevin; Kozikowski, Alan; Jain, Sarika; Cristofanilli, Massimo; Giles, Francis; O'Halloran, Thomas; Cryns, Vincent L; Mazar, Andrew P

Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging

基于抗体的 uPA/uPAR 信号通路 PET 成像技术具有广泛的癌症成像应用前景。

Yang, Dongzhi; Severin, Gregory W; Dougherty, Casey A; Lombardi, Rachel; Chen, Daiqin; Van Dort, Marcian E; Barnhart, Todd E; Ross, Brian D; Mazar, Andrew P; Hong, Hao

Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars

负载适体的金纳米星的生物分布和体内毒性

Dam, Duncan Hieu M; Culver, Kayla S B; Kandela, Irawati; Lee, Raymond C; Chandra, Kavita; Lee, Hyojin; Mantis, Christine; Ugolkov, Andrey; Mazar, Andrew P; Odom, Teri W